Khalida N/a Yasmin, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2601 Little Elm Pkwy Ste 1204, Little Elm, TX 75068 Phone: 972-292-0300 Fax: 972-292-0301 |
Mrs. Ashlee Marie Henderson, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 2700 E Eldorado Pkwy Ste 104b, Little Elm, TX 75068 Phone: 972-987-0458 |
David A Slater, MD Family Medicine - Adult Medicine Medicare: May Accept Medicare Assignments Practice Location: 1395 E Eldorado Pkwy Ste 400, Little Elm, TX 75068 Phone: 469-200-5974 Fax: 469-200-5214 |
Dr. Priscilla Owusu-frimpong, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 11700 Fm 423, Ste 250, Little Elm, TX 75068 Phone: 718-213-9595 |
Nisha Gajendra, Family Medicine Medicare: Medicare Enrolled Practice Location: 2587 Fm 423 Ste 130, Little Elm, TX 75068 Phone: 972-200-4780 Fax: 844-363-2590 |
Dr. Trevor Kyle Huber, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 E Eldorado Pkwy Ste 108, Little Elm, TX 75068 Phone: 972-987-0458 Fax: 972-695-8811 |
News Archive
"Many innovative solutions are being proposed to help tackle the spread of counterfeit drugs in developing countries," GlobalVoices reports. The blog includes highlights from several news articles and blog posts on the topic, including a number of solutions used to identify such drugs.
New research suggests pneumonia in COVID-19 patients is linked to viral-induced changes in the brain. MRI scans revealed 57.9% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients had recent brain lesions.
Older men who drink as few as two drinks twice a week and also have diseases that could be worsened by alcohol or cause problems with medications taken while drinking alcohol have higher death rates, as compared to men who either drink less or may drink more but don't have such comorbidities.
ImmunoCellular Therapeutics today announced the results of a study in which it was shown that certain specific antigens are highly expressed on cancer stem cells (CSCs). This suggests that IMUC's lead cancer vaccine product candidate ICT-107, which targets those antigens, may effectively target not only the cells that make up the bulk of certain cancerous tumors, but also the CSCs that are widely believed to give rise to them and cause their recurrence.
Shire plc, the global specialty biopharmaceutical company, announces that the Food and Drug Administration (FDA), following a thorough administrative review of governing statutory and regulatory standards and public comments, has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
› Verified 7 days ago